Vaso Corporation
VASO
$0.1315
-$0.0057-4.16%
| Weiss Ratings | VASO - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | C- | |||
| Rating Factors | VASO - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Good | |||
| Solvency Index | Good | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | VASO - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.08 | |||
| Price History | VASO - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -4.71% | |||
| 30-Day Total Return | -9.31% | |||
| 60-Day Total Return | 7.79% | |||
| 90-Day Total Return | -9.37% | |||
| Year to Date Total Return | 15.25% | |||
| 1-Year Total Return | -56.17% | |||
| 2-Year Total Return | -48.93% | |||
| 3-Year Total Return | 87.86% | |||
| 5-Year Total Return | 474.24% | |||
| 52-Week High % Change | -57.12% | |||
| 52-Week Low % Change | 24.39% | |||
| Price | VASO - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.32 | |||
| 52-Week Low Price | $0.11 | |||
| 52-Week Low Price (Date) | Jan 15, 2025 | |||
| 52-Week High Price (Date) | Apr 02, 2024 | |||
| Valuation | VASO - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 24.08M | |||
| Enterprise Value | -566.05K | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.01 | |||
| Earnings Per Share Growth | -112.33% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.29 | |||
| Price/Book (Q) | 0.94 | |||
| Enterprise Value/Revenue (TTM) | -0.01 | |||
| Price | $0.13 | |||
| Enterprise Value/EBITDA (TTM) | -0.35 | |||
| Enterprise Value/EBIT | -0.74 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | VASO - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 175.47M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | VASO - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 516 997 4600 | |||
| Address | 137 Commercial Street Plainview, NY 11803 | |||
| Website | vasocorporation.com | |||
| Country | United States | |||
| Year Founded | 1987 | |||
| Profitability | VASO - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 0.93% | |||
| Profit Margin | -0.14% | |||
| Management Effectiveness | VASO - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 0.65% | |||
| Return on Equity | -- | |||
| Income Statement | VASO - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 81.65M | |||
| Total Revenue (TTM) | 81.65M | |||
| Revenue Per Share | $0.47 | |||
| Gross Profit (TTM) | 48.88M | |||
| EBITDA (TTM) | 1.63M | |||
| EBIT (TTM) | 763.00K | |||
| Net Income (TTM) | -118.00K | |||
| Net Income Avl. to Common (TTM) | -118.00K | |||
| Total Revenue Growth (Q YOY) | 6.79% | |||
| Earnings Growth (Q YOY) | -198.58% | |||
| EPS Diluted (TTM) | -0.01 | |||
| EPS Diluted Growth (Q YOY) | -247.06% | |||
| Balance Sheet | VASO - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 26.84M | |||
| Cash Per Share (Q) | $0.15 | |||
| Total Current Assets (Q) | 42.99M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 25.66M | |||
| Current Ratio (Q) | 1.425 | |||
| Book Value Per Share (Q) | $0.15 | |||
| Total Assets (Q) | 73.94M | |||
| Total Current Liabilities (Q) | 30.17M | |||
| Total Debt (Q) | 2.19M | |||
| Total Liabilities (Q) | 48.29M | |||
| Total Common Equity (Q) | 25.66M | |||
| Cash Flow | VASO - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 13.83M | |||
| Cash from Financing (TTM) | -94.00K | |||
| Net Change in Cash (TTM) | 15.79M | |||
| Levered Free Cash Flow (TTM) | -216.20K | |||
| Cash from Operations (TTM) | 2.08M | |||
